PDCD1LG2 and neoplasm: In addition to the expression of the ligands of PD1 (PD-L1 and PD-L2), other important parameters likely include the presence of immune cells within the tumor tissue, tumor mutational burden, genome repair ability, and the presence of a favorable cytokine context [8].